FDA approves first drug to delay onset of Type 1 diabetes

(SILVER SPRING, Md.) -- For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes. Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio... Read More.

The COVID-19 virus can cause diabetes, new studies find

(NEW YORK) -- There is troubling news for those infected with the COVID-19 virus. New studies have found that the virus may cause diabetes in addition to pneumonia and other health problems. Most people will recover from COVID without longer-term problems, but doctors have noticed... Read More.